Orion Biotech Opportunities P/E Ratio

Orion Biotech Opportunities (ORIA) currently reports a P/E ratio of 11.12. That is below the sector sector average of 33.83. Use the charts on this page to explore Orion Biotech Opportunities's P/E ratio history and peer comparisons.

Orion Biotech Opportunities's P/E ratio of 11.12 is lower than the its sector sector average of 33.83. That is roughly 67.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Orion Biotech Opportunities's market price to a fundamental measure such as earnings, sales, or book value. At 11.12, ORIA can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 11.12, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 33.83. From there, open related valuation or income-statement pages for Orion Biotech Opportunities, and consider following ORIA for alerts when major investors trade the stock.